Study of Efficacy and Safety of Investigational Treatment in Patients With Hidradenitis Suppurativa
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04989517 |
Recruitment Status :
Recruiting
First Posted : August 4, 2021
Last Update Posted : April 13, 2022
|
Sponsor:
Azora Therapeutics Australia Pty Ltd
Information provided by (Responsible Party):
Azora Therapeutics Inc. ( Azora Therapeutics Australia Pty Ltd )
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Recruiting |
---|---|
Estimated Primary Completion Date : | June 15, 2022 |
Estimated Study Completion Date : | June 15, 2022 |